Theratechnologies shareholders approve acquisition by Future Pak affiliate

MONTREAL - Theratechnologies Inc. (TSX:TH) (NASDAQ:THTX), a biopharmaceutical company with a market capitalization of $874 million and current trading price of $8.76, announced Friday that shareholders have approved the previously announced plan of arrangement with CB Biotechnology, LLC, an affiliate of Future Pak, LLC.

At the special meeting held Friday, the arrangement received approval from 97.44% of votes cast by shareholders present or represented by proxy. The plan also secured 97.43% approval from minority shareholders, meeting requirements under Multilateral Instrument 61-101. The strong shareholder support comes as Theratechnologies has demonstrated impressive momentum, with a 58.82% price return over the past six months, according to InvestingPro data.

The transaction still requires a final order from the Superior Court of Québec, with a hearing scheduled for September 16, 2025.

Theratechnologies is a specialty biopharmaceutical company that focuses on commercializing innovative therapies. Future Pak, founded in 1977 and headquartered in Wixom, Michigan, operates as a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products.

The arrangement remains subject to customary closing conditions, including court approval and the completion of Future Pak’s anticipated debt financing related to the transaction.

The information in this article is based on a press release statement from Theratechnologies. Financial details of the transaction were not disclosed in the announcement.

In other recent news, Target Hospitality Corp reported its second-quarter earnings for 2025, surpassing revenue expectations with $62 million compared to the projected $59.43 million. However, the company’s earnings per share (EPS) came in at -$0.1223, slightly below the anticipated -$0.11. Additionally, Target Hospitality announced a significant move into the data center sector with a multi-year contract valued at $43 million, which will run through September 2027. This contract is expected to generate approximately $5 million in 2025. Stifel has responded to these developments by upgrading Target Hospitality’s stock rating from Hold to Buy, citing the company’s entry into the data center business as a key factor. Stifel also raised its price target for the company from $7.50 to $11.00. These recent developments reflect Target Hospitality’s strategic expansion and financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.